Nubeqa (darolutamide)
pCPA File Number:
21244
Negotiation Status:
Under consideration for negotiation
Indication(s):
non-metastatic castrate resistant prostate cancer
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
pCODR 10196
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable